Pregabalin beneficial effects on sleep quality or health-related quality of life are poorly correlated with reduction on pain intensity after an 8-week treatment course

Clinical Neuropharmacology

Volumn 35, Issue 1, 2012, Pages 21-24

  Perez Lloret, Santiago ^a   Rojas, Gloria Meza ^b   Menoni, Maria Celia ^c   Ruiz, Gabriela ^d   Velásquez, Carolina ^b   Rodriguez, Hernán ^d   Rey, María Verónica ^a   Cardinali, And Daniel P ^e  

^a UNIVERSITÉ PAUL SABATIER   (France)

^b Instituto Mutual de la Salud   (Paraguay)

^c Servicio de Endocrinología y Metabolismo Del Hospital Central   (Paraguay)

^d Centro Médico Santa Clara   (Paraguay)

^e PONTIFICIA UNIVERSIDAD CATÓLICA ARGENTINA   (Argentina)

Author keywords

health related quality of life; pain; pregabalin; sleep quality

Indexed keywords

PREGABALIN;

ADULT; ANALGESIA; ARTICLE; CORRELATIONAL STUDY; DIZZINESS; EUROQOL HEALTH STATE VISUOANALOGIC SCALE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROPATHIC PAIN; NUMERICAL RATING SCALE; OPEN STUDY; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PAIN INTENSITY; PAIN PARAMETERS; PITTSBURGH SLEEP QUALITY INDEX; PRIORITY JOURNAL; QUALITY OF LIFE; QUALITY OF LIFE INDEX; RATING SCALE; SLEEP QUALITY; SOMNOLENCE; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT;

ANALGESICS; FEMALE; FOLLOW-UP STUDIES; GAMMA-AMINOBUTYRIC ACID; HEALTH STATUS INDICATORS; HUMANS; MALE; MIDDLE AGED; NEURALGIA; PAIN MEASUREMENT; QUALITY OF LIFE; QUESTIONNAIRES; SLEEP DISORDERS; STATISTICS AS TOPIC; TREATMENT OUTCOME;

EID: 84855830919     PISSN: 03625664     EISSN: 1537162X     Source Type: Journal    
DOI: 10.1097/WNF.0b013e31823df2dc     Document Type: Article

References (20)

1. Hamandi K, Sander JW. Pregabalin: a new antiepileptic drug for refractory epilepsy. Seizure 2006;15:73-78. (Pubitemid 43192415)
2. Joshi I, Taylor CP. Pregabalin action at a model synapse: binding to presynaptic calcium channel alpha2-delta subunit reduces neurotransmission in mice. Eur J Pharmacol 2006;553:82-88. (Pubitemid 44779589)
3. Errante LD, Petroff OA. Acute effects of gabapentin and pregabalin on rat forebrain cellular GABA, glutamate, and glutamine concentrations. Seizure 2003;12:300-306. (Pubitemid 36806076)
4. Fehrenbacher JC, Taylor CP, Vasko MR. Pregabalin and gabapentin reduce release of substance P and CGRP from rat spinal tissues only after inflammation or activation of protein kinase C. Pain 2003;105:133-141. (Pubitemid 37162482)
5. Taylor CP, Angelotti T, Fauman E. Pharmacology and mechanism of action of pregabalin: the calcium channel alpha2-delta (alpha2-delta) subunit as a target for antiepileptic drug discovery. Epilepsy Res 2007;73:137-150. (Pubitemid 46329329)
6. Durkin B, Page C, Glass P. Pregabalin for the treatment of postsurgical pain. Expert Opin Pharmacother 2010;11:2751-2758.
7. Roth T, van SR, Murphy TK. The effect of pregabalin on pain-related sleep interference in diabetic peripheral neuropathy or postherpetic neuralgia: a review of nine clinical trials. Curr Med Res Opin 2010;26:2411-2419.
8. Attal N, Cruccu G, Baron R, et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol 2010;17:1113-1123.
9. Wu SC, Wrobel JS, Armstrong DG. Assessing the impact of pharmacologic intervention on the quality of life in diabetic peripheral neuropathic pain and fibromyalgia. Pain Med 2007;8(Suppl 2):S33-S42. (Pubitemid 47288509)
10. Hoffman DL, Sadosky A, Dukes EM, et al. How do changes in pain severity levels correspond to changes in health status and function in patients with painful diabetic peripheral neuropathy? Pain 2010;149:194-201.
11. Dworkin RH, Turk DC, Farrar JT, et al. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain 2005;113:9-19. (Pubitemid 40038441)
12. Buysse DJ, Reynolds CF III, Monk TH, et al. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989;28:193-213. (Pubitemid 19144991)
13. Brooks R. EuroQol: the current state of play. Health Policy 1996;37:53-72. (Pubitemid 26191458)
14. Marks DM, Pae CU, Patkar AA. Potential role of pregabalin in the treatment of lithium-induced tremor: a case report. Int J Neuropsychopharmacol 2008;11:879-881.
15. Rickels K, Pollack MH, Feltner DE, et al. Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam. Arch Gen Psychiatry 2005;62:1022-1030. (Pubitemid 41248382)
16. Tzellos TG, Toulis KA, Goulis DG, et al. Gabapentin and pregabalin in the treatment of fibromyalgia: a systematic review and a meta-analysis. J Clin Pharm Ther 2010;35:639-656.
17. Kubota T, Fang J, Meltzer LT, et al. Pregabalin enhances nonrapid eye movement sleep. J Pharmacol Exp Ther 2001;299:1095-1105. (Pubitemid 33104981)
18. Hindmarch I, Dawson J, Stanley N. A double-blind study in healthy volunteers to assess the effects on sleep of pregabalin compared with alprazolam and placebo. Sleep 2005;28:187-193. (Pubitemid 40362644)
19. Allen R, Chen C, Soaita A, et al. A randomized, double-blind, 6-week, dose-ranging study of pregabalin in patients with restless legs syndrome. Sleep Med 2010;11:512-519.
20. Kyle SD, Morgan K, Espie CA. Insomnia and health-related quality of life. Sleep Med Rev 2010;14:69-82.